CRO概念+AI医疗概念联动2连板！诺思格10时16分再度涨停，背后逻辑揭晓

Group 1 - The core viewpoint of the article highlights that Norsg has achieved a consecutive two-day limit-up in trading, indicating strong market interest and performance [1] - The stock reached a trading limit at 10:16 AM with a transaction volume of 549 million yuan and a turnover rate of 11.75% [1] - The healthcare service sector has seen an overall rise, with Norsg being a clinical CRO company that offers comprehensive clinical trial services [1] Group 2 - Norsg has developed an AI platform that integrates clinical trial protocols and medical literature data, applicable in various clinical research scenarios [1] - The improvement in profit expectations following the implementation of innovative drug insurance negotiations and the shift of overseas orders to domestic markets are key factors driving the stock's performance [1] - The increasing market attention towards AI in healthcare is also contributing to the stock's upward momentum [1]